CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,998,000 | -55.3% | 80,635 | -69.2% | 0.00% | -40.0% |
Q3 2021 | $4,472,000 | +121.7% | 261,536 | +73.6% | 0.01% | +150.0% |
Q2 2021 | $2,017,000 | +675.8% | 150,635 | +3080.0% | 0.00% | +100.0% |
Q3 2020 | $260,000 | +165.3% | 4,737 | -67.1% | 0.00% | 0.0% |
Q3 2019 | $98,000 | -80.0% | 14,389 | -72.7% | 0.00% | -75.0% |
Q2 2019 | $490,000 | +252.5% | 52,644 | +427.5% | 0.00% | +100.0% |
Q1 2019 | $139,000 | -3.5% | 9,979 | -24.2% | 0.00% | +100.0% |
Q4 2018 | $144,000 | +166.7% | 13,165 | +232.4% | 0.00% | 0.0% |
Q1 2018 | $54,000 | +20.0% | 3,961 | -28.0% | 0.00% | 0.0% |
Q4 2015 | $45,000 | +164.7% | 5,500 | +95.8% | 0.00% | – |
Q3 2015 | $17,000 | +30.8% | 2,809 | +83.7% | 0.00% | – |
Q2 2015 | $13,000 | -68.3% | 1,529 | -71.9% | 0.00% | -100.0% |
Q1 2015 | $41,000 | -50.0% | 5,444 | -54.5% | 0.00% | 0.0% |
Q4 2014 | $82,000 | +46.4% | 11,965 | -3.9% | 0.00% | 0.0% |
Q3 2014 | $56,000 | +51.4% | 12,446 | +97.7% | 0.00% | 0.0% |
Q2 2014 | $37,000 | -61.1% | 6,296 | -55.8% | 0.00% | -50.0% |
Q1 2014 | $95,000 | -31.7% | 14,260 | -40.4% | 0.00% | 0.0% |
Q4 2013 | $139,000 | – | 23,946 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |